16.10.2012 • NewsSongwonPolysysJV

Songwon, Pan Gulf, Polysys Form Songwon Additives Technology

Today, Songwon Industrial Group, Pan Gulf Holdings of Saudi Arabia and Polysys Industries of Abu Dhabi proudly announce the establishment of their joint venture, Songwon Additives Technology, for the manufacture and sale of Songnox OPS.

This follows the signature of a Memorandum of Understanding (MoU) among the three partners announced on December 14, 2011.

Songwon Additives Technology, a holding company based in Switzerland, owns 100% of Songwon ATG (formerly Additives Technology Greiz), a European manufacturers of One Pack Systems (OPS), and is at an advanced stage of establishing manufacturing companies in the Middle East and United States.

In addition Songwon Additives Technology will establish a wholly owned subsidiary, Songwon Additives Technology Middle East, for the sale of Songnox OPS and other Songwon products. Sales of Songnox OPS in the rest of the world will be channeled through the existing Songwon sales and distribution network.

 

 

 

 

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.